0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lyophilized Recombinant Human Brain Natriuretic Peptide Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-10N13891
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Lyophilized Recombinant Human Brain Natriuretic Peptide Market Research Report 2023
BUY CHAPTERS

Global Lyophilized Recombinant Human Brain Natriuretic Peptide Market Research Report 2025

Code: QYRE-Auto-10N13891
Report
May 2025
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Lyophilized Recombinant Human Brain Natriuretic Peptide Market

The global market for Lyophilized Recombinant Human Brain Natriuretic Peptide was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Lyophilized Recombinant Human Brain Natriuretic Peptide is indicated for the intravenous treatment of patients with acute decompensated heart failure who have dyspnea at rest or with mild activity.
North American market for Lyophilized Recombinant Human Brain Natriuretic Peptide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Lyophilized Recombinant Human Brain Natriuretic Peptide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Lyophilized Recombinant Human Brain Natriuretic Peptide include Novartis, Chengdu Rhodiola Bio-Pharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Lyophilized Recombinant Human Brain Natriuretic Peptide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lyophilized Recombinant Human Brain Natriuretic Peptide.
The Lyophilized Recombinant Human Brain Natriuretic Peptide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lyophilized Recombinant Human Brain Natriuretic Peptide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lyophilized Recombinant Human Brain Natriuretic Peptide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Lyophilized Recombinant Human Brain Natriuretic Peptide Market Report

Report Metric Details
Report Name Lyophilized Recombinant Human Brain Natriuretic Peptide Market
Segment by Type
  • 0.5mg
  • 1.5mg
Segment by Application
  • Adult
  • Child
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, Chengdu Rhodiola Bio-Pharmaceutical Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Lyophilized Recombinant Human Brain Natriuretic Peptide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Lyophilized Recombinant Human Brain Natriuretic Peptide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Lyophilized Recombinant Human Brain Natriuretic Peptide Market report?

Ans: The main players in the Lyophilized Recombinant Human Brain Natriuretic Peptide Market are Novartis, Chengdu Rhodiola Bio-Pharmaceutical Co., Ltd.

What are the Application segmentation covered in the Lyophilized Recombinant Human Brain Natriuretic Peptide Market report?

Ans: The Applications covered in the Lyophilized Recombinant Human Brain Natriuretic Peptide Market report are Adult, Child

What are the Type segmentation covered in the Lyophilized Recombinant Human Brain Natriuretic Peptide Market report?

Ans: The Types covered in the Lyophilized Recombinant Human Brain Natriuretic Peptide Market report are 0.5mg, 1.5mg

1 Lyophilized Recombinant Human Brain Natriuretic Peptide Market Overview
1.1 Product Definition
1.2 Lyophilized Recombinant Human Brain Natriuretic Peptide by Type
1.2.1 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Market Value Comparison by Type (2024 VS 2031)
1.2.2 0.5mg
1.2.3 1.5mg
1.3 Lyophilized Recombinant Human Brain Natriuretic Peptide by Application
1.3.1 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Market Value by Application (2024 VS 2031)
1.3.2 Adult
1.3.3 Child
1.4 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Market Size Estimates and Forecasts
1.4.1 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue 2020-2031
1.4.2 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales 2020-2031
1.4.3 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Lyophilized Recombinant Human Brain Natriuretic Peptide Market Competition by Manufacturers
2.1 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Market Share by Manufacturers (2020-2025)
2.2 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Lyophilized Recombinant Human Brain Natriuretic Peptide, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Lyophilized Recombinant Human Brain Natriuretic Peptide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lyophilized Recombinant Human Brain Natriuretic Peptide, Product Type & Application
2.7 Global Key Manufacturers of Lyophilized Recombinant Human Brain Natriuretic Peptide, Date of Enter into This Industry
2.8 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Market Competitive Situation and Trends
2.8.1 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Lyophilized Recombinant Human Brain Natriuretic Peptide Players Market Share by Revenue
2.8.3 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Market Scenario by Region
3.1 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Region: 2020-2031
3.2.1 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Region: 2020-2025
3.2.2 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Region: 2026-2031
3.3 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Region: 2020-2031
3.3.1 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Region: 2020-2025
3.3.2 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Region: 2026-2031
3.4 North America Lyophilized Recombinant Human Brain Natriuretic Peptide Market Facts & Figures by Country
3.4.1 North America Lyophilized Recombinant Human Brain Natriuretic Peptide Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Country (2020-2031)
3.4.3 North America Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lyophilized Recombinant Human Brain Natriuretic Peptide Market Facts & Figures by Country
3.5.1 Europe Lyophilized Recombinant Human Brain Natriuretic Peptide Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Country (2020-2031)
3.5.3 Europe Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lyophilized Recombinant Human Brain Natriuretic Peptide Market Facts & Figures by Region
3.6.1 Asia Pacific Lyophilized Recombinant Human Brain Natriuretic Peptide Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Region (2020-2031)
3.6.3 Asia Pacific Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Lyophilized Recombinant Human Brain Natriuretic Peptide Market Facts & Figures by Country
3.7.1 Latin America Lyophilized Recombinant Human Brain Natriuretic Peptide Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Country (2020-2031)
3.7.3 Latin America Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lyophilized Recombinant Human Brain Natriuretic Peptide Market Facts & Figures by Country
3.8.1 Middle East and Africa Lyophilized Recombinant Human Brain Natriuretic Peptide Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Country (2020-2031)
3.8.3 Middle East and Africa Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Type (2020-2031)
4.1.1 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Type (2020-2025)
4.1.2 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Type (2026-2031)
4.1.3 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Market Share by Type (2020-2031)
4.2 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Type (2020-2031)
4.2.1 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Type (2020-2025)
4.2.2 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Type (2026-2031)
4.2.3 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Market Share by Type (2020-2031)
4.3 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Price by Type (2020-2031)
5 Segment by Application
5.1 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Application (2020-2031)
5.1.1 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Application (2020-2025)
5.1.2 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Application (2026-2031)
5.1.3 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Market Share by Application (2020-2031)
5.2 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Application (2020-2031)
5.2.1 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Application (2020-2025)
5.2.2 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Application (2026-2031)
5.2.3 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Market Share by Application (2020-2031)
5.3 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Lyophilized Recombinant Human Brain Natriuretic Peptide Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Lyophilized Recombinant Human Brain Natriuretic Peptide Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Chengdu Rhodiola Bio-Pharmaceutical Co., Ltd.
6.2.1 Chengdu Rhodiola Bio-Pharmaceutical Co., Ltd. Company Information
6.2.2 Chengdu Rhodiola Bio-Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Chengdu Rhodiola Bio-Pharmaceutical Co., Ltd. Lyophilized Recombinant Human Brain Natriuretic Peptide Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Chengdu Rhodiola Bio-Pharmaceutical Co., Ltd. Lyophilized Recombinant Human Brain Natriuretic Peptide Product Portfolio
6.2.5 Chengdu Rhodiola Bio-Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lyophilized Recombinant Human Brain Natriuretic Peptide Industry Chain Analysis
7.2 Lyophilized Recombinant Human Brain Natriuretic Peptide Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lyophilized Recombinant Human Brain Natriuretic Peptide Production Mode & Process Analysis
7.4 Lyophilized Recombinant Human Brain Natriuretic Peptide Sales and Marketing
7.4.1 Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Channels
7.4.2 Lyophilized Recombinant Human Brain Natriuretic Peptide Distributors
7.5 Lyophilized Recombinant Human Brain Natriuretic Peptide Customer Analysis
8 Lyophilized Recombinant Human Brain Natriuretic Peptide Market Dynamics
8.1 Lyophilized Recombinant Human Brain Natriuretic Peptide Industry Trends
8.2 Lyophilized Recombinant Human Brain Natriuretic Peptide Market Drivers
8.3 Lyophilized Recombinant Human Brain Natriuretic Peptide Market Challenges
8.4 Lyophilized Recombinant Human Brain Natriuretic Peptide Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Lyophilized Recombinant Human Brain Natriuretic Peptide Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Lyophilized Recombinant Human Brain Natriuretic Peptide, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Lyophilized Recombinant Human Brain Natriuretic Peptide, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Lyophilized Recombinant Human Brain Natriuretic Peptide, Product Type & Application
 Table 12. Global Key Manufacturers of Lyophilized Recombinant Human Brain Natriuretic Peptide, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Lyophilized Recombinant Human Brain Natriuretic Peptide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lyophilized Recombinant Human Brain Natriuretic Peptide as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Region (2020-2025) & (K Units)
 Table 18. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Market Share by Region (2020-2025)
 Table 19. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Region (2026-2031) & (K Units)
 Table 20. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Market Share by Region (2026-2031)
 Table 21. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Market Share by Region (2020-2025)
 Table 23. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Market Share by Region (2026-2031)
 Table 25. North America Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Country (2020-2025) & (K Units)
 Table 27. North America Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Country (2026-2031) & (K Units)
 Table 28. North America Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Lyophilized Recombinant Human Brain Natriuretic Peptide Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales (K Units) by Type (2020-2025)
 Table 51. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales (K Units) by Type (2026-2031)
 Table 52. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Market Share by Type (2020-2025)
 Table 53. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Market Share by Type (2026-2031)
 Table 54. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Market Share by Type (2020-2025)
 Table 57. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Market Share by Type (2026-2031)
 Table 58. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales (K Units) by Application (2020-2025)
 Table 61. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales (K Units) by Application (2026-2031)
 Table 62. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Market Share by Application (2020-2025)
 Table 63. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Market Share by Application (2026-2031)
 Table 64. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Market Share by Application (2020-2025)
 Table 67. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Market Share by Application (2026-2031)
 Table 68. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Price (US$/Unit) by Application (2026-2031)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis Lyophilized Recombinant Human Brain Natriuretic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novartis Lyophilized Recombinant Human Brain Natriuretic Peptide Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. Chengdu Rhodiola Bio-Pharmaceutical Co., Ltd. Company Information
 Table 76. Chengdu Rhodiola Bio-Pharmaceutical Co., Ltd. Description and Business Overview
 Table 77. Chengdu Rhodiola Bio-Pharmaceutical Co., Ltd. Lyophilized Recombinant Human Brain Natriuretic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Chengdu Rhodiola Bio-Pharmaceutical Co., Ltd. Lyophilized Recombinant Human Brain Natriuretic Peptide Product
 Table 79. Chengdu Rhodiola Bio-Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 80. Key Raw Materials Lists
 Table 81. Raw Materials Key Suppliers Lists
 Table 82. Lyophilized Recombinant Human Brain Natriuretic Peptide Distributors List
 Table 83. Lyophilized Recombinant Human Brain Natriuretic Peptide Customers List
 Table 84. Lyophilized Recombinant Human Brain Natriuretic Peptide Market Trends
 Table 85. Lyophilized Recombinant Human Brain Natriuretic Peptide Market Drivers
 Table 86. Lyophilized Recombinant Human Brain Natriuretic Peptide Market Challenges
 Table 87. Lyophilized Recombinant Human Brain Natriuretic Peptide Market Restraints
 Table 88. Research Programs/Design for This Report
 Table 89. Key Data Information from Secondary Sources
 Table 90. Key Data Information from Primary Sources
 Table 91. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Lyophilized Recombinant Human Brain Natriuretic Peptide
 Figure 2. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Market Share by Type: 2024 & 2031
 Figure 4. 0.5mg Product Picture
 Figure 5. 1.5mg Product Picture
 Figure 6. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Market Share by Application: 2024 & 2031
 Figure 8. Adult
 Figure 9. Child
 Figure 10. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales (2020-2031) & (K Units)
 Figure 13. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Average Price (US$/Unit) & (2020-2031)
 Figure 14. Lyophilized Recombinant Human Brain Natriuretic Peptide Report Years Considered
 Figure 15. Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Share by Manufacturers in 2024
 Figure 16. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Lyophilized Recombinant Human Brain Natriuretic Peptide Players: Market Share by Revenue in Lyophilized Recombinant Human Brain Natriuretic Peptide in 2024
 Figure 18. Lyophilized Recombinant Human Brain Natriuretic Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Market Share by Country (2020-2031)
 Figure 21. North America Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Market Share by Country (2020-2031)
 Figure 22. United States Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Market Share by Country (2020-2031)
 Figure 25. Europe Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Market Share by Region (2020-2031)
 Figure 33. China Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Lyophilized Recombinant Human Brain Natriuretic Peptide by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Lyophilized Recombinant Human Brain Natriuretic Peptide by Type (2020-2031)
 Figure 52. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Lyophilized Recombinant Human Brain Natriuretic Peptide by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Lyophilized Recombinant Human Brain Natriuretic Peptide by Application (2020-2031)
 Figure 55. Global Lyophilized Recombinant Human Brain Natriuretic Peptide Price (US$/Unit) by Application (2020-2031)
 Figure 56. Lyophilized Recombinant Human Brain Natriuretic Peptide Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String